Fred Alger Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.55M Buy
95,783
+1,672
+2% +$75K 0.02% 237
2025
Q4
$2.99M Sell
94,111
-2,950
-3% -$92K 0.01% 286
2025
Q3
$2.73M Buy
97,061
+96
+0.1% +$2.91K 0.01% 301
2025
Q2
$3.57M Sell
96,965
-241,303
-71% -$8.34M 0.02% 273
2025
Q1
$13.3M Sell
338,268
-422,956
-56% -$19M 0.08% 144
2024
Q4
$35.4M Sell
761,224
-5,925
-0.8% -$268K 0.17% 91
2024
Q3
$34.7M Buy
767,149
+112,272
+17% +$5.34M 0.17% 94
2024
Q2
$32.3M Buy
654,877
+575,080
+721% +$23.5M 0.16% 97
2024
Q1
$2.74M Buy
79,797
+50,550
+173% +$1.82M 0.01% 316
2023
Q4
$1.08M Buy
+29,247
New +$676K 0.01% 367
2023
Q3
Sell
-26,587
Closed -$544K 537
2023
Q2
$544K Buy
+26,587
New +$398K ﹤0.01% 397
2022
Q1
Sell
-33,628
Closed -$2.6M 558
2021
Q4
$2.6M Buy
+33,628
New +$3.45M 0.01% 342
2021
Q3
Sell
-101,010
Closed -$13.5M 564
2021
Q2
$13.5M Buy
+101,010
New +$11.7M 0.03% 235
2021
Q1
Sell
-47,523
Closed -$6.71M 511
2020
Q4
$6.71M Sell
47,523
-16,514
-26% -$1.83M 0.02% 261
2020
Q3
$4.87M Sell
64,037
-6,932
-10% -$432K 0.01% 244
2020
Q2
$3.21M Buy
70,969
+46,969
+196% +$1.69M 0.01% 272
2020
Q1
$734K Buy
+24,000
New +$645K ﹤0.01% 336
2019
Q4
Sell
-5,500
Closed -$131K 526
2019
Q3
$131K Buy
5,500
+3,000
+120% +$87.2K ﹤0.01% 407
2019
Q2
$73K Buy
+2,500
New +$66.1K ﹤0.01% 416

Other funds holding TWST

Fred Alger Management's TWST Position: Q1 2026 in Review

Fred Alger Management increased its Twist Bioscience (TWST) stake by 1.8% in Q1 2026, buying an estimated $75K and bringing the position to 95,783 shares worth $4.55M. The position accounts for 0.02% of the portfolio, ranked #237.

Fred Alger Management first reported a position in TWST in Q2 2019 and has held it in 19 quarters since. The position peaked at $35.4M in Q4 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Fred Alger Management held 95,783 shares of Twist Bioscience worth $4.55M as of Q1 2026.
  • Fred Alger Management bought 1,672 Twist Bioscience shares in Q1 2026, an estimated $75K.
  • Twist Bioscience made up 0.02% of Fred Alger Management's portfolio in Q1 2026, its #237 holding.
  • Fred Alger Management first reported a position in Twist Bioscience in Q2 2019 and has held it in 19 quarters since.
  • Fred Alger Management's Twist Bioscience position peaked at $35.4M in Q4 2024.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.